Innovative solution for epilepsy diagnosis and monitoring
Location: France, Ile-of-France, Paris
Employees: 501-1000
Total raised: $74.01M
Founded date: 2013
Investors 4
| Date | Name | Website |
| - | LBO France | lbofrance.... |
| - | Idinvest P... | idinvest.c... |
| - | Kurma Part... | kurmapartn... |
| - | StartX | startx.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.06.2019 | Series B | $74.01M | - |
Mentions in press and media 4
| Date | Title | Description |
| 23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders Mental illness is considered the silent pandemic that's been overlooked since the start of COVID. The World Health Organization found the g... |
| 04.08.2022 | BioSerenity, Inc. appoints new leadership in North America | BioSerenity, Inc., a company specializing in research & remote diagnostic solutions for neurology & sleep medicine, announces Jeff Wren as CEO of North America ATLANTA, GA, UNITED STATES, August 4, 2022 /EINPresswire.com/ -- BioSere... |
| 21.06.2019 | BioSerenity Raises €65M in Series B Equity Funding | BioSerenity, a Paris, France-based developer of solutions dedicated to personalized patient continuous care, raises €65m in Series B equity funding. The round was led by Dassault Systèmes (Euronext Paris: #13065, DSY.PA), which invested €50... |
| - | BioSerenity | “BioSerenity” |